| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.02 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |